Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Axitinib (AG-013736).
Kelly RJ, Rixe O. Kelly RJ, et al. Among authors: rixe o. Recent Results Cancer Res. 2010;184:33-44. doi: 10.1007/978-3-642-01222-8_3. Recent Results Cancer Res. 2010. PMID: 20072829 Review.
Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
Chen Y, Rini BI, Motzer RJ, Dutcher JP, Rixe O, Wilding G, Stadler WM, Tarazi J, Garrett M, Pithavala YK. Chen Y, et al. Among authors: rixe o. Target Oncol. 2016 Apr;11(2):229-34. doi: 10.1007/s11523-015-0389-2. Target Oncol. 2016. PMID: 26400730 Free PMC article.
Renal toxicity of targeted therapies.
Kelly RJ, Billemont B, Rixe O. Kelly RJ, et al. Among authors: rixe o. Target Oncol. 2009 Apr;4(2):121-33. doi: 10.1007/s11523-009-0109-x. Epub 2009 May 6. Target Oncol. 2009. PMID: 19421832 Review.
Diastolic blood pressure as a biomarker of axitinib efficacy in solid tumors.
Rini BI, Schiller JH, Fruehauf JP, Cohen EE, Tarazi JC, Rosbrook B, Bair AH, Ricart AD, Olszanski AJ, Letrent KJ, Kim S, Rixe O. Rini BI, et al. Among authors: rixe o. Clin Cancer Res. 2011 Jun 1;17(11):3841-9. doi: 10.1158/1078-0432.CCR-10-2806. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531811
152 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page